Tim Hagenacker
Overview
Explore the profile of Tim Hagenacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cordts I, Fuetterer C, Wachinger A, von Heynitz R, Kessler T, Freigang M, et al.
Neurology
. 2025 Feb;
104(5):e213371.
PMID: 39946662
Background And Objectives: The availability of disease-modifying therapies for 5q-associated spinal muscular atrophy (SMA) has heightened the need to identify suitable biomarkers. This study investigates neurofilament light chain (NfL) concentrations...
2.
Ullrich D, Fuhrer D, Heuer H, Mayerl S, Haupeltshofer S, Schmitt L, et al.
Eur Thyroid J
. 2025 Jan;
14(1).
PMID: 39841728
Objective: Thyroid hormones control a variety of processes in the central nervous system and influence its response to different stimuli, such as ischemic stroke. Post-stroke administration of 3,3',5-triiodo-L-thyronine (T3) has...
3.
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, et al.
J Neurol Neurosurg Psychiatry
. 2025 Jan;
PMID: 39798960
Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions, leading to fluctuating muscle weakness. While many patients respond well to standard immunosuppression, a substantial subgroup faces ongoing disease...
4.
Goerttler T, Dorner M, van der Linden C, Kienitz R, Petrik S, Blechinger S, et al.
Neurol Res Pract
. 2024 Oct;
6(1):52.
PMID: 39472968
Background: Intragastric botulinum neurotoxin injections (IBNI) are offered off-label in the private medical sector in a few European countries as a safe and effective weight-loss measure. In February and March...
5.
Kruse T, Leflerova D, Cap A, Portegys S, Wirth B, Heller R, et al.
Orphanet J Rare Dis
. 2024 Oct;
19(1):382.
PMID: 39407277
Background: Oral function tests have been shown to reliably detect impaired bulbar function in adults with spinal muscular atrophy (SMA). Although not routinely recorded, it is known that persons with...
6.
Stolte B, Neuhoff S, Lipka J, Schlag M, von Velsen O, Kruse T, et al.
Muscle Nerve
. 2024 Oct;
70(6):1223-1229.
PMID: 39360659
Introduction/aims: Persons with spinal muscular atrophy (pwSMA) report progressive muscle weakness but also reduced endurance when performing repetitive tasks in daily life, referred to as "performance fatigability" (PF). Data regarding...
7.
Dobelmann V, Roos A, Hentschel A, Marina A, Leo M, Schmitt L, et al.
J Neurol
. 2024 Sep;
271(10):7000-7011.
PMID: 39240344
Background And Purpose: Spinal muscular atrophy (SMA) as the second most common neurodegenerative disorder in childhood is characterized by the deficiency of survival of motor neuron (SMN) protein leading predominantly...
8.
Hagenacker T, Maggi L, Coratti G, Youn B, Raynaud S, Paradis A, et al.
Neurol Ther
. 2024 Sep;
13(5):1483-1504.
PMID: 39222296
Introduction: Nusinersen clinical trials have limited data on adolescents and adults with 5q-associated spinal muscular atrophy (SMA). We conducted a systematic literature review (SLR) and meta-analysis to assess effectiveness of...
9.
Arteaga-Bracho E, Cosne G, Kanzler C, Karatsidis A, Mazza C, Penalver-Andres J, et al.
J Neuromuscul Dis
. 2024 Jul;
11(5):1049-1065.
PMID: 38995798
Background: More responsive, reliable, and clinically valid endpoints of disability are essential to reduce size, duration, and burden of clinical trials in adult persons with spinal muscular atrophy (aPwSMA). Objective:...
10.
Linse K, Weber C, Reilich P, Schoberl F, Boentert M, Petri S, et al.
Neurol Res Pract
. 2024 Jul;
6(1):34.
PMID: 38961496
Introduction: Amyotrophic lateral sclerosis (ALS) is an inevitably fatal condition that leads to a progressive loss of physical functioning, which results in a high psychosocial burden and organizational challenges related...